Goodwin Procter advised ACELYRIN on the deal.ACELYRIN announced the completion of its $300 million Series C financing round which was led by Access Biotechnology with participation from…
ACELYRIN’s $300 Million Series C Financing Round


Goodwin Procter advised ACELYRIN on the deal.ACELYRIN announced the completion of its $300 million Series C financing round which was led by Access Biotechnology with participation from…
…